Pfizer Payout Strains: Income Investors Face Hard Truth
Pfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
Find out which cash back cards offer the best options for 2023. Stay updated with the latest offerings to maximize your rewards.
26,992 articlesPfizer paid more in dividends than its free cash flow in 2025, a warning sign for income investors facing hard realit...
A crypto-focused venture outfit scores a $1.2 billion fund rise, signaling a major shift toward AI and robotics along...
When a well-known fund exits a position, it invites scrutiny. This fund dumped million in Graphic Packaging as shares...
Amazon delivered a blockbuster Q1 2026, but a record capex plan raises questions about the stock’s two-year path. Her...
After a sharp drop in Robinhood stock, investors wonder what comes next. This article breaks down scenarios, real-wor...
In early 2026, Tutor Perini faced a mix of growth opportunities and project-level headwinds. This article breaks down...
A major fund plowed into a top U.S. homebuilder with a $65 million stake, ahead of a rumored $47-per-share buyout. He...
Kick off your week with 10 Sunday reads that translate heavy market chatter into actionable investing moves. Each ite...
When rates rise, many buyers pause. But for seasoned STR investors, higher interest rates turbocharging profits can u...
A 72-year-old couple evaluated a continuing care retirement community with an $880,000 entrance fee and $7,400 monthl...
When a professional advisor exits a stake in TREX, it can signal shifts in strategy or risk controls. This guide brea...
Stock crashes test nerves and portfolios. This article breaks down Warren Buffett's rule dealing with crashes and sho...